Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol
Cardiovascular Fixed Combination Pill ASR: Pharmacodynamic Clinical Trial of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril (Cardiovascular Polypill); LDL Cholesterol
Sponsor: Ferrer Internacional S.A.
Terminated
Per sponsor's decision
Other terminated trials from Ferrer Internacional S.A.
- Amyotrophic Lateral Sclerosis · Phase PHASE3 · Feb 2024
- Compensated Heart Failure · Phase PHASE4 · Dec 2012
- Acute Stroke · Phase PHASE3 · Mar 2012
- Dermatomycoses · Phase PHASE4 · Nov 2011
- Elevated LDL Cholesterol · Phase PHASE2 · Mar 2011
More terminations from Ferrer Internacional S.A.
Other Elevated LDL Cholesterol trials with similar outcome
Listed as NCT01362218, this PHASE2 trial focuses on Elevated LDL Cholesterol and remains terminated or withdrawn. Sponsored by Ferrer Internacional S.A., it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Oct 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ferrer Internacional S.A.
For direct contact, visit the study record on ClinicalTrials.gov .